Logo

Neogenomics

People in the News: New Appointments at NeoGenomics, Mainz Biomed, IsoPlexis, More

Genetron Health, NeoGenomics Partner on Oncology Drug Clinical Trials and Testing

The companies will provide help with clinical drug trials and companion diagnostics projects that need a China arm for global or China-focused trials.

NeoGenomics Preparing for Commercialization of Inivata MRD Test in 2022
Premium

The firm's RaDaR test looks at 48 known mutations for MRD monitoring and has received breakthrough device designation from the FDA.

NeoGenomics Q3 Revenues Drop 3 Percent

Excluding COVID-19 revenue, the firm's revenues were up 12 percent year over year and clinical services revenue rose 11 percent.

Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies

Inivata's InVisionFirst-Lung and RaDaR assays will support studies of the use of liquid biopsies in early and minimal residual disease detection.

Aug 6, 2021

NeoGenomics Q2 Revenues Grow 40 Percent

May 7, 2021

NeoGenomics Expects Inivata Buy to Help it Penetrate MRD Monitoring Market
Premium

Apr 19, 2021

Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC

Apr 15, 2021

Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing
Premium

Apr 8, 2021

Trapelo Health, Magellan Rx Team on Value-Based Precision Oncology

Mar 24, 2021

NeoGenomics Acquires Trapelo Health in $65M Deal

Mar 16, 2021

NeoGenomics, Elevation Oncology Partner on NRG1 Fusion Testing for Clinical Trial Enrollment

Feb 24, 2021

NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

Feb 4, 2021

NeoGenomics, Parexel Partner to Improve Precision Oncology Trial Research

Jan 22, 2021

NeoGenomics to Grow Pharma, Informatics Divisions Through CDx Agreements, Acquisitions
Premium

Jan 12, 2021

JP Morgan Healthcare Conference 2021, Day 2: Roche, Seer, 10x, Guardant, Hologic, Thermo Fisher

Jan 7, 2021

NeoGenomics Prices $500M Offering of Stock, Senior Notes

Dec 11, 2020

BTIG Initiates Coverage of NeoGenomics With Buy Rating

Oct 27, 2020

NeoGenomics Q3 Revenues Rise 20 Percent

Sep 18, 2020

People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More

Jul 28, 2020

NeoGenomics Expects Q3 Revenue Growth as it Expands Liquid Biopsy Offerings, COVID-19 Testing
Premium

Jul 28, 2020

NeoGenomics Q2 Revenues Fall 14 Percent

Jul 2, 2020

New Products Posted to GenomeWeb: Twist Bioscience, NeoGenomics, Flagship Biosciences

Jun 9, 2020

NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program

May 26, 2020

NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test

Breaking News
The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.